AllianceBernstein’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-314,412
Closed -$47.5M 3384
2022
Q3
$47.5M Sell
314,412
-37,465
-11% -$5.66M 0.02% 546
2022
Q2
$51.3M Sell
351,877
-291,459
-45% -$42.5M 0.02% 542
2022
Q1
$76.3M Sell
643,336
-510,992
-44% -$60.6M 0.03% 484
2021
Q4
$159M Buy
1,154,328
+78,494
+7% +$10.8M 0.06% 313
2021
Q3
$149M Sell
1,075,834
-324,086
-23% -$45M 0.06% 307
2021
Q2
$136M Sell
1,399,920
-56,639
-4% -$5.5M 0.05% 336
2021
Q1
$99.6M Buy
1,456,559
+251,355
+21% +$17.2M 0.04% 403
2020
Q4
$103M Sell
1,205,204
-243,960
-17% -$20.9M 0.05% 372
2020
Q3
$94.2M Buy
1,449,164
+230,636
+19% +$15M 0.05% 342
2020
Q2
$89.1M Sell
1,218,528
-297,282
-20% -$21.7M 0.05% 343
2020
Q1
$51.6M Sell
1,515,810
-98,380
-6% -$3.35M 0.04% 434
2019
Q4
$87.9M Sell
1,614,190
-296,991
-16% -$16.2M 0.05% 361
2019
Q3
$79.7M Buy
1,911,181
+504,090
+36% +$21M 0.05% 370
2019
Q2
$61.6M Sell
1,407,091
-56,018
-4% -$2.45M 0.04% 479
2019
Q1
$75.3M Buy
1,463,109
+72,090
+5% +$3.71M 0.05% 392
2018
Q4
$51.4M Sell
1,391,019
-193,963
-12% -$7.17M 0.04% 462
2018
Q3
$59.5M Sell
1,584,982
-216,398
-12% -$8.13M 0.04% 456
2018
Q2
$71.2M Buy
1,801,380
+343,353
+24% +$13.6M 0.05% 399
2018
Q1
$37.6M Sell
1,458,027
-139,729
-9% -$3.6M 0.03% 573
2017
Q4
$43.1M Buy
1,597,756
+733,526
+85% +$19.8M 0.03% 529
2017
Q3
$32.3M Buy
864,230
+429,021
+99% +$16M 0.02% 614
2017
Q2
$10.9M Buy
+435,209
New +$10.9M 0.01% 895